Header Logo

Connection

Holly Branthoover to Neoplasms, Second Primary

Back to Details
This is a "connection" page, showing publications Holly Branthoover has written about Neoplasms, Second Primary.
Holly Branthoover
Connection Strength
0.184
Neoplasms, Second Primary
  1. Combination Nivolumab, CD137 Agonism, and Adoptive Cell Therapy with Tumor-Infiltrating Lymphocytes for Patients with Metastatic Melanoma. Clin Cancer Res. 2022 12 15; 28(24):5317-5329.
    View in: PubMed
    Score: 0.184
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.